Literature DB >> 33870725

An Implementation Framework for Telemedicine to Address Noncommunicable Diseases in Thailand.

Pairoj Chattranukulchai1, Nuntakorn Thongtang2, Vuddhidej Ophascharoensuk3, Sombat Muengtaweepongsa4, Chaisiri Angkurawaranon3, Kittiphan Chalom5, Somruethai Supungul6, Jadej Thammatacharee6, Suneerat Kittikhun7, Prapimporn Ch Shantavasinkul8, Pattara Leelahavarong9, Petch Rawdaree10, Sasithorn Tangsawad11, Siriwan Pitayarangsarit11, Chanikarn Kanaderm12, Anunchai Assawamakin13, Weranuj Roubsanthisuk2, Apichard Sukonthasarn14.   

Abstract

To maintain the continuity of noncommunicable disease (NCD) services and ascertain the health outcomes of patients with NCDs during the COVID-19 (coronavirus disease 2019) outbreak in Thailand, various telemedicine services have been developed. To achieve this determination, the implementation framework has been constructed based on recommendations from multidisciplinary experts (Thai NCD Collaboration Group). Within the framework, all key elements are illustrated with their priority and expected collaborations. Ultimately, active collaborations from multi-stakeholders are vitally important to ensure that telemedicine services for NCDs will finally become practical, successful, and sustainable.

Entities:  

Keywords:  health care services; health communication; noncommunicable diseases; population health; telemedicine

Year:  2021        PMID: 33870725     DOI: 10.1177/10105395211008754

Source DB:  PubMed          Journal:  Asia Pac J Public Health        ISSN: 1010-5395            Impact factor:   1.399


  2 in total

1.  Development of a DIY rehabilitation device for lower limb weakness in acute to subacute ischemic stroke.

Authors:  Noppamad Tangmanee; Sombat Muengtaweepongsa; Wiroj Limtrakarn
Journal:  MethodsX       Date:  2021-11-25

2.  Implementation of diabetes care and educational program via telemedicine in patients with COVID-19 in home isolation in Thailand: A real-worldexperience.

Authors:  Tasma Harindhanavudhi; Chatvara Areevut; Taninee Sahakitrungruang; Thipaporn Tharavanij; Pongtorn Kietdumrongwong; Orasa Ngimruksa; Patitta Songsiri; Siwadon Pitukweerakul; Nattamon Tanathornkirati; Natthapon Kaewprasert; Ruchirek Thamcharoen; Krittadhee Karndumri; Sunee Saetung; Pimjai Anthanont; Pornpimol Kiattisakthavee; Sarapee Putkong; Phawinpon Chotwanvirat; Chorthip Nartsupha Phattanasri; Srikorn Jinadit; Sira Korpaisarn; Manusvinee Chusane; Rattanapan Samittarucksa; Amornpan Lertrit; Sanguansak Siangruangsang; Kanokporn Sanpawithayakul; Waraporn Sathiravikarn; Sataporn Soisuwan; Parawee Chevaisrakul; Kanokporn Imsakul; Pinradakarn Thuptimtong; Jandanee Sakmanarit; Supaporn Somwang; Hussamon Prasartkaew; Ratanaporn Jerawatana; Siriwan Butadej; Porntip Tachanivate; Wallaya Jongjaroenprasert; Jeeraphan Sripatong; Sunanta Chobtangsilp; Pattraphorn Kamnirdsittiseree; Benjaporn Savetkairop; Warot Manosittisak; Jitra Tantivatanasatien; Amornrat Hathaidechadusadee; Sirimon Reutrakul
Journal:  J Diabetes Investig       Date:  2022-04-25       Impact factor: 3.681

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.